Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse. - Carter TL; Watt PM; Kumar R; Burton PR; Reaman GH; Sather HN; Baker DL; Kees UR (Blood, 2001)